Ecabet sodium, also known as TA-2711, is a drug used for treating ulcers and gastritis. It works by inhibiting pepsin activity, protecting the stomach lining’s mucous layer, and reducing the activity of Helicobacter pylori, a bacterium that can cause ulcers. Ecabet sodium is also marketed in Japan as an oral agent for treating gastric ulcers and gastritis. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Sulfodehydroabietic acid monosodium salt and Ecabet sodium salt. Its PubChem CID is 23663982.
Ecabet sodium
| CAS No | 86408-72-2 |
|---|---|
| Molecular Formula | C20H27NaO5S |
| Molecular Weight | 402.5 g/mol |
| Synonyms | sodium;(4bS,8R,8aR)-8-carboxy-4b,8-dimethyl-2-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthrene-3-sulfonate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ecabet sodium, also known as TA-2711, is a drug used for treating ulcers and gastritis. It works by inhibiting pepsin activity, protecting the stomach lining's mucous layer, and reducing the activity of Helicobacter pylori, a bacterium that can cause ulcers.
The listed CAS number is 86408-72-2.
The listed molecular formula is C20H27NaO5S.
The listed molecular weight is 402.5 g/mol.
sodium;(4bS,8R,8aR)-8-carboxy-4b,8-dimethyl-2-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthrene-3-sulfonate.
The source lists Sulfodehydroabietic acid monosodium salt and Ecabet sodium salt.